Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
The future of perioperative therapy in advanced renal cell carcinoma: How can we PROSPER?
Hiten D. Patel
, Maneka Puligandla
, Brian M. Shuch
, Bradley C. Leibovich
, Anil Kapoor
, Viraj A. Master
, Charles G. Drake
, Daniel Y.C. Heng
, Primo N. Lara
, Toni K. Choueiri
, Deborah Maskens
, Eric A. Singer
, Scott E. Eggener
,
Robert S. Svatek
, Walter M. Stadler
, Suzanne Cole
, Sabina Signoretti
, Rajan T. Gupta
, Marc Dror Michaelson
, David F. McDermott
David Cella, Lynne I. Wagner, Naomi B. Haas, Michael A. Carducci, Lauren C. Harshman, Mohamad E. Allaf
Show 6 others
Show less
Department of Urology
Research output
:
Contribution to journal
›
Article
›
peer-review
36
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The future of perioperative therapy in advanced renal cell carcinoma: How can we PROSPER?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Patient
100%
Surgery
83%
Diseases
33%
Malignant Neoplasm
33%
Kidney Cancer
33%
Renal Cell Carcinoma
33%
Nivolumab
33%
Perioperative
16%
Combination Therapy
16%
Neoplasm
16%
Disease Control
16%
Nephrectomy
16%
Drug
16%
Anticarcinogen
16%
Electric Potential
16%
Death
16%
Medicine and Dentistry
Surgery
83%
Diseases
33%
Malignant Neoplasm
33%
Clear Cell Renal Cell Carcinoma
33%
Kidney Cancer
33%
Nivolumab
33%
Neoplasm
16%
Combination Therapy
16%
Anticarcinogen
16%
Immune System
16%
Nephrectomy
16%
Drug
16%
Chemotherapeutic Agent
16%
Kidney
16%
Fighting
16%